National Institute on Drug Abuse

NCT07825857

CollaboratorPhase 2Not yet recruiting2026228 people17 Sept 2026clinicaltrials.gov

NCT07783555

CollaboratorPhase 2Not yet recruiting2026224 people25 Aug 2026clinicaltrials.gov

NCT07602699

CollaboratorPhase 2Recruiting2026300 people22 May 2026clinicaltrials.gov

NCT07468552

Phase 2Not yet recruiting2026100 people12 Mar 2026clinicaltrials.gov

NCT07227948

CollaboratorPhase 2Recruiting202675 people13 Nov 2025clinicaltrials.gov

NCT06829238

CollaboratorPhase 4Recruiting2025100 people17 Feb 2025clinicaltrials.gov

NCT06651177

CollaboratorPhase 2Recruiting2026310 people21 Oct 2024clinicaltrials.gov

NCT06609369

CollaboratorPhase 2Recruiting2025114 people24 Sept 2024clinicaltrials.gov

NCT06582888

CollaboratorEarly phase 1Recruiting2024200 people3 Sept 2024clinicaltrials.gov

NCT06548490

CollaboratorPhase 2Recruiting2025200 people12 Aug 2024clinicaltrials.gov

NCT06015893

Phase 2Active, not recruiting202363 people29 Aug 2023clinicaltrials.gov

NCT05891587

CollaboratorPhase 2Completed202380 people7 Jun 2023clinicaltrials.gov

NCT05610072

CollaboratorEarly phase 1Completed202212 people9 Nov 2022clinicaltrials.gov

NCT05530577

CollaboratorPhase 2Completed202224 people7 Sept 2022clinicaltrials.gov

NCT04602494

CollaboratorPhase 4Terminated20205 people26 Oct 2020clinicaltrials.gov

NCT04273880

CollaboratorPhase 1Status unknown2018146 people18 Feb 2020clinicaltrials.gov

NCT04199728

CollaboratorPhase 1/2Completed202127 people16 Dec 2019clinicaltrials.gov

NCT04198116

CollaboratorPhase 2Completed2020167 people13 Dec 2019clinicaltrials.gov

NCT04191278

CollaboratorPhase 4Withdrawn20210 people9 Dec 2019clinicaltrials.gov

NCT04155632

CollaboratorPhase 2Completed202032 people7 Nov 2019clinicaltrials.gov

Charles Carusi

N01POPULATION ASSESSMENT OF TOBACCO AND HEALTH (PATH) STUDY PERIOD OF PERFORMANCE: 02/01/2024 - 11/30/2030.75N95024C002024–2029reporter.nih.gov

Westat

N01POPULATION ASSESSMENT OF TOBACCO AND HEALTH (PATH) STUDY PERIOD OF PERFORMANCE: 02/01/2024 - 11/30/2030.75N95024C00US$36.3k2024–2029reporter.nih.gov

Charles River Laboratories Intntl, Inc.

N01DEVELOPMENT AND MAINTENANCE OF A MULTIGENOTYPIC AGED MOUSE COLONY27120160000US$152.1k2024–2025reporter.nih.gov

Coriell Institute for Medical Research

N01SELECTION, PRODUCTION, CHARACTERIZATION AND DISTRIBUTION OF CULTURED CELLS AND DNA FOR RESEARCH ON AGING75N95025C00US$2m2025–2026reporter.nih.gov

Charles River Laboratories Intntl, Inc.

N01TASK ORDER 4 FOR THE DEVELOPMENT AND MAINTENANCE OF A MULTIGENOTYPIC AGED MOUSE COLONY.75N95022D00US$7.2m2025–2026reporter.nih.gov

Clemetric, Llc

N02MANAGEMENT OF THE PRIMATE AGING DATABASE.27120180002US$178k2018–2025reporter.nih.gov

Charles River Laboratories Intntl, Inc.

N01DEVELOPMENT AND MAINTENANCE OF A MULTIGENOTYPIC AGED MOUSE COLONY27120170000US$18.5k2018–2020reporter.nih.gov

Charles River Laboratories Intntl, Inc.

N01DEVELOPMENT AND MAINTENANCE OF A MULTIGENOTYPIC AGED RAT COLONY27120170000US$2.9m2025–2026reporter.nih.gov

Charles River Laboratories Intntl, Inc.

N01DEVELOPMENT AND MAINTENANCE OF A MULTIGENOTYPIC AGED MOUSE COLONY27120160000US$53.2k2019–2020reporter.nih.gov

Charles River Laboratories Intntl, Inc.

N01DEVELOPMENT AND MAINTENANCE OF A MULTIGENOTYPIC CALORIC RESTRICTED RODENT COLONY27120120000US$11.4k2019–2020reporter.nih.gov

Heather Simmons

N01DEVELOPMENT AND MAINTENANCE OF A NON-HUMAN PRIMATE TISSUE BANK75N95023C002023–2026reporter.nih.gov

University of Wisconsin-madison

N01DEVELOPMENT AND MAINTENANCE OF A NON-HUMAN PRIMATE TISSUE BANK75N95023C00US$146.4k2023–2026reporter.nih.gov

Warren Ladiges

N01DEVELOPMENT AND MAINTENANCE OF AN AGED RODENT TISSUE BANKPERIOD OF PERFORMANCE: 3/15/2021 - 3/14/202275N95021C002021–2026reporter.nih.gov

University of Washington

N01DEVELOPMENT AND MAINTENANCE OF AN AGED RODENT TISSUE BANKPERIOD OF PERFORMANCE: 3/15/2021 - 3/14/202275N95021C00US$308.9k2021–2026reporter.nih.gov

Sergio Urias

N01DEVELOPMENT AND MAINTENANCE OF A MULTIGENOTYPIC AGED RAT COLONY271201700002024–2025reporter.nih.gov

Charles River Laboratories Intntl, Inc.

N01DEVELOPMENT AND MAINTENANCE OF A MULTIGENOTYPIC AGED RAT COLONY27120170000US$117.5k2024–2025reporter.nih.gov

Rita Z Goldstein

R01Atherosclerosis in cocaine addiction: imaging risk with PET/MRR01DA0495472022–202717 Sept 2026reporter.nih.gov

Zahi A. Fayad

R01Atherosclerosis in cocaine addiction: imaging risk with PET/MRR01DA0495472022–202717 Sept 2026reporter.nih.gov

Nelly Alia-Klein

R01Atherosclerosis in cocaine addiction: imaging risk with PET/MRR01DA0495472022–202717 Sept 2026reporter.nih.gov

Icahn School of Medicine at Mount Sinai

R01Atherosclerosis in cocaine addiction: imaging risk with PET/MRR01DA049547US$151.2k2022–202717 Sept 2026reporter.nih.gov

Prevalence of abnormal spirometry and correlates of lung function decline among a population in rural Uganda

K24DA0616962 Oct 2026pubmed.ncbi.nlm.nih.gov

Predictors of cigarette discontinuation and reduction among adults never planning to quit smoking: Longitudinal findings from the U.S. Population Assessment of Tobacco and Health (PATH) study, 2014/15-2021

30 Sept 2026pubmed.ncbi.nlm.nih.gov

Speech clocks decode dementia phenotypes, social exposome, and biological aging

30 Sept 2026pubmed.ncbi.nlm.nih.gov

Increasing Multimorbidity Burden After COVID-19 Infection Among People With and Without HIV in the United States: Insights From the National Clinical Cohort Collaborative (N3C)

18 Sept 2026pubmed.ncbi.nlm.nih.gov

The GrimAge clock corresponds to brain ageing and social determinants of health in people with HIV

EBioMedicine24 Sept 2026